Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Phase Il Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior

NCT07193901 is registered in ClinicalTrials.gov with Sichuan Purity Pharmaceutical Technology Co., Ltd. as lead sponsor.

NCT NCT07193901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07193901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Phase Il Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior
Lead sponsor
Sichuan Purity Pharmaceutical Technology Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
May 27, 2025
Completion date
June 1, 2026
Enrollment
98 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd